| 000 | 01532 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250518022704.0 | ||
| 264 | 0 | _c20200515 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1879-0852 | ||
| 024 | 7 |
_a10.1016/j.ejca.2019.01.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDutertre, Martin | |
| 245 | 0 | 0 |
_aCold agglutinin disease as a new immune-related adverse event associated with anti-PD-L1s and its treatment with rituximab. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _c03 2019 |
||
| 300 |
_a21-23 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnemia, Hemolytic, Autoimmune _xchemically induced |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aB7-H1 Antigen _ximmunology |
| 650 | 0 | 4 |
_aCarcinoma, Papillary _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aRituximab _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _ade Menthon, Mathilde | |
| 700 | 1 | _aNoël, Nicolas | |
| 700 | 1 | _aAlbiges, Laurence | |
| 700 | 1 | _aLambotte, Olivier | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 110 _gp. 21-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2019.01.009 _zAvailable from publisher's website |
| 999 |
_c29348642 _d29348642 |
||